Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium

NCT06694792 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06694792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06694792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
January 3, 2025
Completion date
December 31, 2026
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ipmn, pancreatic